Gedatolisib
id:
gedatolisib-189-3895461
title:
Gedatolisib
text:
Gedatolisib (PF-05212384) is an experimental drug for treatment of cancer in development by Celcuity, Inc. The mechanism of action is accomplished by binding the different p110 catalytic subunit isoforms of PI3K and the kinase site of mTOR. The drug was originally developed by Wyeth, which Pfizer acquired in 2009. Gedatolisib is under development for patients with and without PIK3CA mutations.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Gedatolisib
date created:
2017-09-11T14:17:43Z
date modified:
2024-09-09T05:13:14Z
main entity:
{"identifier":"Q27077788","url":"https://www.wikidata.org/entity/Q27077788"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/66/Gedatolisib.svg","width":512,"height":234}
fields total:
13
integrity:
16